Financial Management Professionals’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Hold
8
﹤0.01% 749
2026
Q1
$2K Hold
8
﹤0.01% 730
2025
Q4
$2.2K Hold
8
﹤0.01% 711
2025
Q3
$2.1K Sell
8
-1
-11% -$243 ﹤0.01% 710
2025
Q2
$1.97K Buy
9
+8
+800% +$1.71K ﹤0.01% 753
2025
Q1
$224 Sell
1
-10
-91% -$2.76K ﹤0.01% 950
2024
Q4
$3.6K Buy
+11
New +$3.46K ﹤0.01% 662
2023
Q2
Sell
-11
Closed -$4K 1141
2023
Q1
$4K Buy
+11
New +$3.21K ﹤0.01% 738
2022
Q2
Sell
-11
Closed -$5K 1150
2022
Q1
$5K Buy
+11
New +$4.31K ﹤0.01% 650

Other funds holding WST

Financial Management Professionals's WST Position: Q2 2026 in Review

Financial Management Professionals held its West Pharmaceutical (WST) position steady in Q2 2026 at 8 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Financial Management Professionals first reported a position in WST in Q1 2022 and has held it in 9 quarters since. The position peaked at $5K in Q1 2022. 126 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Financial Management Professionals held 8 shares of West Pharmaceutical worth $2.87K as of Q2 2026.
  • Financial Management Professionals left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #749 holding.
  • Financial Management Professionals first reported a position in West Pharmaceutical in Q1 2022 and has held it in 9 quarters since.
  • Financial Management Professionals's West Pharmaceutical position peaked at $5K in Q1 2022.
  • 126 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.